Novo Integrated Sciences, Inc. (NVOS)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.21 Million USD | 59.77% |
| 2022 | -32.84 Million USD | -636.18% |
| 2021 | -4.46 Million USD | 9.22% |
| 2020 | -4.91 Million USD | -1153.92% |
| 2019 | -391.98 Thousand USD | 81.41% |
| 2018 | -2.1 Million USD | -185.49% |
| 2017 | -738.38 Thousand USD | -347.81% |
| 2016 | -164.88 Thousand USD | 94.05% |
| 2015 | -2.77 Million USD | -168.08% |
| 2014 | -1.03 Million USD | -16.43% |
| 2013 | -887.67 Thousand USD | 23.49% |
| 2012 | -1.16 Million USD | 48.16% |
| 2011 | -2.23 Million USD | 12.89% |
| 2010 | -2.56 Million USD | -13.09% |
| 2009 | -2.27 Million USD | -131.2% |
| 2008 | -982.67 Thousand USD | 60.22% |
| 2007 | -2.47 Million USD | -68.62% |
| 2006 | -1.46 Million USD | -37.08% |
| 2005 | -1.06 Million USD | -278.97% |
| 2004 | -282 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -13.74 Million USD | -400.41% |
| 2024 Q1 | -4.68 Million USD | -48.09% |
| 2024 Q2 | -2.74 Million USD | 41.33% |
| 2023 Q1 | -3.93 Million USD | 82.45% |
| 2023 Q4 | -3.16 Million USD | -111.07% |
| 2023 FY | -13.21 Million USD | 59.77% |
| 2023 Q3 | -1.49 Million USD | 67.6% |
| 2023 Q2 | -4.62 Million USD | -17.43% |
| 2022 FY | -32.84 Million USD | -636.18% |
| 2022 Q1 | -1.8 Million USD | 6.86% |
| 2022 Q4 | -22.42 Million USD | -488.64% |
| 2022 Q3 | -3.81 Million USD | 20.71% |
| 2022 Q2 | -4.8 Million USD | -165.98% |
| 2021 Q1 | -771.47 Thousand USD | 81.74% |
| 2021 Q3 | -411.18 Thousand USD | 69.31% |
| 2021 Q4 | -1.93 Million USD | -371.71% |
| 2021 FY | -4.46 Million USD | 9.22% |
| 2021 Q2 | -1.33 Million USD | -73.68% |
| 2020 FY | -4.91 Million USD | -1153.92% |
| 2020 Q1 | -88.12 Thousand USD | -212.7% |
| 2020 Q2 | -504.48 Thousand USD | -472.5% |
| 2020 Q3 | -98.29 Thousand USD | 80.52% |
| 2020 Q4 | -4.22 Million USD | -4197.53% |
| 2019 Q1 | -251.41 Thousand USD | -58.85% |
| 2019 FY | -391.98 Thousand USD | 81.41% |
| 2019 Q4 | 78.19 Thousand USD | 178.78% |
| 2019 Q2 | -119.5 Thousand USD | 52.47% |
| 2019 Q3 | -99.25 Thousand USD | 16.94% |
| 2018 FY | -2.1 Million USD | -185.49% |
| 2018 Q4 | -158.26 Thousand USD | 27.37% |
| 2018 Q3 | -217.89 Thousand USD | 84.15% |
| 2018 Q2 | -1.37 Million USD | -284.72% |
| 2018 Q1 | -357.28 Thousand USD | -24.77% |
| 2017 FY | -738.38 Thousand USD | -347.81% |
| 2017 Q4 | -286.35 Thousand USD | 19.73% |
| 2017 Q3 | -356.74 Thousand USD | -863.57% |
| 2017 Q2 | -37.02 Thousand USD | 12.83% |
| 2017 Q1 | -42.47 Thousand USD | -13.86% |
| 2016 FY | -164.88 Thousand USD | 94.05% |
| 2016 Q4 | -37.3 Thousand USD | -118.78% |
| 2016 Q1 | -35.36 Thousand USD | -166.79% |
| 2016 Q2 | -68.06 Thousand USD | -92.47% |
| 2016 Q3 | -17.05 Thousand USD | 74.95% |
| 2015 Q2 | -2.35 Million USD | -618.82% |
| 2015 Q4 | -13.25 Thousand USD | 96.34% |
| 2015 FY | -2.77 Million USD | -168.08% |
| 2015 Q3 | -362.31 Thousand USD | 84.65% |
| 2015 Q1 | -328.28 Thousand USD | -57.18% |
| 2014 Q3 | -350.48 Thousand USD | -140.24% |
| 2014 FY | -1.03 Million USD | -16.43% |
| 2014 Q1 | -192.35 Thousand USD | -13.49% |
| 2014 Q2 | -145.89 Thousand USD | 24.15% |
| 2014 Q4 | -208.86 Thousand USD | 40.41% |
| 2013 FY | -887.67 Thousand USD | 23.49% |
| 2013 Q1 | -165.24 Thousand USD | 16.92% |
| 2013 Q2 | -242.55 Thousand USD | -46.78% |
| 2013 Q4 | -169.48 Thousand USD | 40.17% |
| 2013 Q3 | -283.28 Thousand USD | -16.79% |
| 2012 Q4 | -198.9 Thousand USD | 48.4% |
| 2012 Q3 | -385.49 Thousand USD | 5.66% |
| 2012 FY | -1.16 Million USD | 48.16% |
| 2012 Q1 | -417.06 Thousand USD | 16.82% |
| 2012 Q2 | -408.61 Thousand USD | 2.03% |
| 2011 FY | -2.23 Million USD | 12.89% |
| 2011 Q3 | -484.57 Thousand USD | 41.96% |
| 2011 Q4 | -501.4 Thousand USD | -3.47% |
| 2011 Q1 | -460.2 Thousand USD | -83.87% |
| 2011 Q2 | -834.96 Thousand USD | -81.43% |
| 2010 Q1 | -884.87 Thousand USD | -39.19% |
| 2010 Q4 | -250.28 Thousand USD | 79.07% |
| 2010 Q2 | -662.97 Thousand USD | 25.08% |
| 2010 Q3 | -1.19 Million USD | -80.36% |
| 2010 FY | -2.56 Million USD | -13.09% |
| 2009 Q3 | -417.58 Thousand USD | -25.13% |
| 2009 FY | -2.27 Million USD | -131.2% |
| 2009 Q4 | -635.75 Thousand USD | -52.25% |
| 2009 Q2 | -333.7 Thousand USD | 4.89% |
| 2009 Q1 | -350.86 Thousand USD | -30.64% |
| 2008 Q1 | -852.96 Thousand USD | -75.24% |
| 2008 Q4 | -268.56 Thousand USD | -45.64% |
| 2008 FY | -982.67 Thousand USD | 60.22% |
| 2008 Q2 | -178.85 Thousand USD | 79.03% |
| 2008 Q3 | -184.4 Thousand USD | -3.1% |
| 2007 Q4 | -486.74 Thousand USD | -6.86% |
| 2007 Q1 | -517.89 Thousand USD | 7.74% |
| 2007 Q3 | -455.49 Thousand USD | 32.53% |
| 2007 FY | -2.47 Million USD | -68.62% |
| 2007 Q2 | -675.15 Thousand USD | -30.36% |
| 2006 FY | -1.46 Million USD | -37.08% |
| 2006 Q3 | -259.73 Thousand USD | -105.97% |
| 2006 Q1 | -278.54 Thousand USD | -132.45% |
| 2006 Q2 | -126.1 Thousand USD | 54.73% |
| 2006 Q4 | -561.34 Thousand USD | -116.12% |
| 2005 FY | -1.06 Million USD | -278.97% |
| 2005 Q2 | -237.24 Thousand USD | 0.0% |
| 2005 Q4 | -119.83 Thousand USD | 72.33% |
| 2005 Q3 | -433.11 Thousand USD | -82.56% |
| 2004 FY | -282 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 39.011% |
| Addus HomeCare Corporation | 62.51 Million USD | 121.138% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -195.034% |
| Amedisys, Inc. | -9.74 Million USD | -35.576% |
| American Oncology Network, Inc. | -5.54 Million USD | -138.444% |
| Astrana Health, Inc. | 60.71 Million USD | 121.764% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 90.177% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 498.509% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -38.784% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 118.194% |
| COMPASS Pathways plc | -118.46 Million USD | 88.845% |
| DocGo Inc. | 6.85 Million USD | 292.675% |
| The Ensign Group, Inc. | 209.39 Million USD | 106.311% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 134.425% |
| InnovAge Holding Corp. | -21.33 Million USD | 38.07% |
| Assure Holdings Corp. | -26.07 Million USD | 49.327% |
| The Joint Corp. | -9.75 Million USD | -35.503% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 92.905% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 15.306% |
| ModivCare Inc. | -204.46 Million USD | 93.537% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 10249.971% |
| Option Care Health, Inc. | 267.09 Million USD | 104.948% |
| P3 Health Partners Inc. | -57.77 Million USD | 77.127% |
| P3 Health Partners Inc. | -57.77 Million USD | 77.127% |
| The Pennant Group, Inc. | 13.37 Million USD | 198.771% |
| Surgery Partners, Inc. | -11.9 Million USD | -11.047% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -349.728% |
| Talkspace, Inc. | -19.18 Million USD | 31.11% |
| Talkspace, Inc. | -19.18 Million USD | 31.11% |
| The Oncology Institute, Inc. | -83.06 Million USD | 84.092% |
| The Oncology Institute, Inc. | -83.06 Million USD | 84.092% |